Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review

Autor: Ghader Mohammadnezhad, Behniya Azadmehr, Nazila Yousefi
Rok vydání: 2022
Předmět:
Zdroj: Expert Review of Pharmacoeconomics & Outcomes Research. 22:1187-1198
ISSN: 1744-8379
1473-7167
DOI: 10.1080/14737167.2022.2130761
Databáze: OpenAIRE